Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control.

Blood
Xiaxin LiLaura S Haneline

Abstract

The pathogenesis of bone marrow failure in Fanconi anemia is poorly understood. Suggested mechanisms include enhanced apoptosis secondary to DNA damage and altered inhibitory cytokine signaling. Recent data determined that disrupted cell cycle control of hematopoietic stem and/or progenitor cells disrupts normal hematopoiesis with increased hematopoietic stem cell cycling resulting in diminished function and increased sensitivity to cell cycle-specific apoptotic stimuli. Here, we used Fanconi anemia complementation type C-deficient (Fancc-/-) mice to demonstrate that Fancc-/- phenotypically defined cell populations enriched for hematopoietic stem and progenitor cells exhibit increased cycling. In addition, we established that the defect in cell cycle regulation is not a compensatory mechanism from enhanced apoptosis occurring in vivo. Collectively, these data provide a previously unrecognized phenotype in Fancc-/- hematopoietic stem/progenitor cells, which may contribute to the progressive bone marrow failure in Fanconi anemia.

References

Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·S H CheshierI L Weissman
Mar 10, 2000·Science·T ChengD T Scadden
Jun 5, 2001·Nature Reviews. Genetics·H Joenje, K J Patel
Jan 2, 2003·Nature Reviews. Cancer·Alan D D'Andrea, Markus Grompe

❮ Previous
Next ❯

Citations

Aug 1, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Amy M Skinner, Peter Kurre
Dec 22, 2009·Human Molecular Genetics·David B RheeYie Liu
Oct 5, 2011·Human Molecular Genetics·Vilma BarrocaPierre Fouchet
Jun 7, 2006·Current Opinion in Hematology·Christa E Muller-Sieburg, Hans B Sieburg
Jun 14, 2008·Blood·Cédric S TremblayMadeleine Carreau
Dec 27, 2012·Disease Models & Mechanisms·Sietske T BakkerHein te Riele
Jun 28, 2012·Anemia·Tagrid Kaddar, Madeleine Carreau
Jan 29, 2014·Proceedings of the National Academy of Sciences of the United States of America·Caroline C HuardMadeleine Carreau
May 12, 2009·Mutation Research·Kalindi ParmarLaura J Niedernhofer
Dec 15, 2015·Scientific Reports·Wei DuQishen Pang
May 28, 2010·Stem Cells·Kalindi ParmarAlan D'andrea
May 27, 2015·British Journal of Haematology·Melissa MantelliMaria Ester Bernardo
Oct 21, 2005·Cytotherapy·S FruehaufJ Topaly
Aug 26, 2014·Experimental Cell Research·Cristina MirantesEric M Pietras
Aug 21, 2004·Blood·Sonia FrancoMaría A Blasco
Dec 20, 2020·Blood Cells, Molecules & Diseases·Elena C BrindleyLionel Blanc

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis